The FAMHP is actively involved in the European pilot project for repurposing authorised medicines for new therapeutic indications. The project was launched at the end of 2021 by the expert group Safe and Timely Access to Medicines for Patients (STAMP) of the European Commission. In this context, the FAMHP is supporting non-profit organisations and academic centres by providing scientific-technical and regulatory advice in the research into the repurposing of existing medicines for new indications.
In order to align the development of innovative drugs more closely to the needs and requests of patients, a pilot project was relaunched to issue advice on the clinical development of new medicinal products. The advice is prepared in consultation with specific patient associations. In 2021, three requests for advice were processed as part of this pilot project.